Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2021

May 07, 2021

SELL
$10.34 - $12.81 $13,245 - $16,409
-1,281 Closed
0 $0
Q4 2020

Feb 12, 2021

SELL
$8.61 - $11.04 $43,351 - $55,586
-5,035 Reduced 79.72%
1,281 $12,000
Q3 2020

Nov 16, 2020

SELL
$8.57 - $12.69 $6,761 - $10,012
-789 Reduced 11.1%
6,316 $57,000
Q2 2020

Aug 12, 2020

SELL
$8.12 - $13.12 $4,279 - $6,914
-527 Reduced 6.91%
7,105 $88,000
Q1 2020

May 15, 2020

SELL
$6.69 - $13.45 $990 - $1,990
-148 Reduced 1.9%
7,632 $69,000
Q4 2019

Feb 14, 2020

SELL
$6.53 - $10.72 $339 - $557
-52 Reduced 0.66%
7,780 $76,000
Q3 2019

Nov 14, 2019

BUY
$6.16 - $9.6 $252 - $393
41 Added 0.53%
7,832 $54,000
Q2 2019

Aug 14, 2019

BUY
$8.12 - $15.72 $12,147 - $23,517
1,496 Added 23.76%
7,791 $72,000
Q1 2019

May 15, 2019

SELL
$15.58 - $20.01 $59,235 - $76,078
-3,802 Reduced 37.65%
6,295 $99,000
Q4 2018

Jan 31, 2019

SELL
$14.59 - $23.84 $6,725 - $10,990
-461 Reduced 4.37%
10,097 $156,000
Q3 2018

Nov 15, 2018

SELL
$21.06 - $25.65 $406,184 - $494,711
-19,287 Reduced 64.62%
10,558 $227,000
Q2 2018

Aug 22, 2018

BUY
$16.77 - $24.71 $436,942 - $643,819
26,055 Added 687.47%
29,845 $726,000
Q2 2018

Aug 15, 2018

SELL
$16.77 - $24.71 $506,152 - $745,797
-30,182 Reduced 88.84%
3,790 $726,000
Q1 2018

May 15, 2018

SELL
$16.68 - $22.07 $11,325 - $14,985
-679 Reduced 1.96%
33,972 $636,000
Q4 2017

Feb 13, 2018

SELL
$11.23 - $19.1 $47,716 - $81,155
-4,249 Reduced 10.92%
34,651 $657,000
Q3 2017

Nov 07, 2017

BUY
$15.41 - $32.17 $599,449 - $1.25 Million
38,900
38,900 $685,000

Others Institutions Holding TEVA

About TEVA PHARMACEUTICAL INDUSTRIES LTD


  • Ticker TEVA
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 1,110,560,000
  • Market Cap $19B
  • Description
  • Teva Pharmaceutical Industries Limited, a pharmaceutical company, develops, manufactures, markets, and distributes generic medicines, specialty medicines, and biopharmaceutical products in North America, Europe, and internationally. The company offers sterile products, hormones, high-potency drugs, and cytotoxic substances in various dosage form...
More about TEVA
Track This Portfolio

Track Advisors Asset Management, Inc. Portfolio

Follow Advisors Asset Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Advisors Asset Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Advisors Asset Management, Inc. with notifications on news.